A detailed history of Hm Payson & CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Hm Payson & CO holds 21,953 shares of LLY stock, worth $18.1 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
21,953
Previous 21,575 1.75%
Holding current value
$18.1 Million
Previous $19.5 Million 0.43%
% of portfolio
0.33%
Previous 0.36%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$772.14 - $960.02 $291,868 - $362,887
378 Added 1.75%
21,953 $19.4 Million
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $1.45 Million - $1.82 Million
-2,002 Reduced 8.49%
21,575 $19.5 Million
Q1 2024

Jun 20, 2024

SELL
$592.2 - $792.28 $487,380 - $652,046
-823 Reduced 3.37%
23,577 $18.3 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $594,515 - $700,855
-1,132 Reduced 4.43%
24,400 $14.2 Million
Q3 2023

Nov 06, 2023

BUY
$434.7 - $599.3 $467,302 - $644,247
1,075 Added 4.4%
25,532 $13.7 Million
Q2 2023

Jul 17, 2023

BUY
$350.74 - $468.98 $1.1 Million - $1.48 Million
3,146 Added 14.76%
24,457 $11.5 Million
Q1 2023

Apr 18, 2023

BUY
$310.63 - $364.82 $441,094 - $518,044
1,420 Added 7.14%
21,311 $7.32 Million
Q4 2022

Feb 06, 2023

SELL
$321.55 - $374.67 $648,244 - $755,334
-2,016 Reduced 9.2%
19,891 $7.28 Million
Q3 2022

Oct 25, 2022

BUY
$296.48 - $337.87 $88,647 - $101,023
299 Added 1.38%
21,907 $7.08 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $17,002 - $19,963
-61 Reduced 0.28%
21,608 $7.01 Million
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $17,367 - $21,582
74 Added 0.34%
21,669 $6.21 Million
Q4 2021

Feb 15, 2022

SELL
$224.85 - $279.04 $87,241 - $108,267
-388 Reduced 1.77%
21,595 $5.97 Million
Q3 2021

Nov 30, 2021

BUY
$221.6 - $272.71 $436,773 - $537,511
1,971 Added 9.85%
21,983 $5.08 Million
Q2 2021

Aug 17, 2021

BUY
$180.55 - $233.54 $32,137 - $41,570
178 Added 0.9%
20,012 $4.59 Million
Q1 2021

Jun 15, 2021

SELL
$164.32 - $212.72 $40,422 - $52,329
-246 Reduced 1.23%
19,834 $3.71 Million
Q4 2020

Mar 10, 2021

SELL
$130.46 - $172.63 $240,959 - $318,847
-1,847 Reduced 8.42%
20,080 $3.39 Million
Q3 2020

Dec 21, 2020

SELL
$146.22 - $169.13 $32,168 - $37,208
-220 Reduced 0.99%
21,927 $3.25 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $22,645 - $27,253
-166 Reduced 0.74%
22,147 $3.64 Million
Q1 2020

Jul 01, 2020

SELL
$119.05 - $147.35 $75,596 - $93,567
-635 Reduced 2.77%
22,313 $3.1 Million
Q4 2019

Feb 18, 2020

SELL
$106.92 - $132.43 $25,126 - $31,121
-235 Reduced 1.01%
22,948 $3.02 Million
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $3,737 - $4,065
35 Added 0.15%
23,183 $2.59 Million
Q2 2019

Aug 15, 2019

SELL
$110.79 - $129.32 $26,700 - $31,166
-241 Reduced 1.03%
23,148 $2.57 Million
Q1 2019

Jul 31, 2019

BUY
$111.31 - $131.02 $2.6 Million - $3.06 Million
23,389 New
23,389 $3.04 Million
Q4 2018

Feb 15, 2019

SELL
$105.9 - $118.64 $2.53 Million - $2.83 Million
-23,891 Closed
0 $0
Q3 2018

Nov 30, 2018

SELL
$85.86 - $107.31 $50,829 - $63,527
-592 Reduced 2.42%
23,891 $2.56 Million
Q2 2018

Aug 27, 2018

SELL
$75.7 - $86.88 $87,130 - $99,998
-1,151 Reduced 4.49%
24,483 $2.09 Million
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $2,745 - $3,241
37 Added 0.14%
25,634 $1.98 Million
Q4 2017

Feb 16, 2018

SELL
$81.94 - $87.89 $140,281 - $150,467
-1,712 Reduced 6.27%
25,597 $2.16 Million
Q3 2017

Nov 06, 2017

BUY
$77.07 - $85.54 $2.1 Million - $2.34 Million
27,309
27,309 $2.34 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $785B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hm Payson & CO Portfolio

Follow Hm Payson & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.